Xeris Biopharma Holdings (XERS) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Xeris Biopharma Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 9 sold $5.4M of XERS stock on the open market.
Get emailed when insiders cluster-buy stocks like XERS
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
XERS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $345K | 3 |
| Q3 2026 | — | 0 | $2.1M | 11 |
| Q2 2026 | — | 0 | $707K | 7 |
| Q1 2026 | — | 0 | $708K | 7 |
| Q4 2025 | — | 0 | $1.5M | 5 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Xeris Biopharma Holdings, Inc. insiders reported open-market purchases totaling $0, while 9 insiders reported sales totaling $5.4M. 32 of 33 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Beth HechtSee Remarks | Sell Plan | 16,6661,111,130 held (−1%) | $9.41 | $157K | +11.4% | — |
| Oct 2SEC | Kevin MccullochSee Remarks | Sell Plan | 15,0001,599,208 held (−1%) | $9.41 | $141K | +11.4% | — |
| Oct 2SEC | Steven PieperSee Remarks | Sell Plan | 5,0001,351,053 held (−0%) | $9.41 | $47K | +11.4% | — |
| Sep 29SEC | Kevin MccullochSee Remarks | Sell Plan | 25,0001,614,208 held (−2%) | $10.00 | $250K | +4.8% | — |
| Sep 1SEC | Beth HechtSee Remarks | Sell Plan | 16,6661,127,796 held (−1%) | $8.49 | $141K | +23.4% | — |
| Sep 1SEC | Kevin MccullochSee Remarks | Sell Plan | 15,0001,639,208 held (−1%) | $8.49 | $127K | +23.4% | — |
| Sep 1SEC | Steven PieperSee Remarks | Sell Plan | 5,0001,356,053 held (−0%) | $8.50 | $42K | +23.3% | — |
| Aug 12SEC | Steven PieperSee Remarks | Sell Plan | 5,0001,361,053 held (−0%) | $8.50 | $42K | +23.3% | — |
| Aug 4SEC | Beth HechtSee Remarks | Sell Plan | 16,6661,144,462 held (−1%) | $8.01 | $133K | +30.8% | — |
| Aug 4SEC | Kevin MccullochSee Remarks | Sell Plan | 15,0001,676,126 held (−1%) | $8.02 | $120K | +30.7% | — |
| Jul 7SEC | Steven PieperSee Remarks | Sell Plan | 27,6001,366,053 held (−2%) | $8.52 | $235K | +23.0% | — |
| Jul 7SEC | Steven PieperSee Remarks | Sell Plan | 17,4001,393,653 held (−1%) | $8.50 | $148K | +23.3% | — |
| Jul 2SEC | Kevin MccullochSee Remarks | Sell Plan | 90,0001,691,126 held (−5%) | $8.03 | $723K | +30.5% | — |
| Jul 2SEC | Beth HechtSee Remarks | Sell Plan | 16,6661,161,128 held (−1%) | $8.03 | $134K | +30.5% | — |
| Jun 5SEC | Dawn HalkuffDirector | Sell Plan | 20,00095,000 held (−17%) | $6.09 | $122K | +72.1% | — |
| Jun 5SEC | Barbara-jean Anne Bormann-kennedyDirector | Sell Plan | 16,000126,500 held (−11%) | $6.09 | $97K | +72.1% | — |
| Jun 5SEC | Marla PerskyDirector | Sell Plan | 15,500126,500 held (−11%) | $5.90 | $91K | +77.6% | — |
| Jun 5SEC | John JohnsonDirector | Sell Plan | 15,000683,083 held (−2%) | $6.09 | $91K | +72.1% | — |
| Jun 2SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,176,506 held (−1%) | $6.06 | $101K | +72.9% | — |
| May 1SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,193,173 held (−1%) | $6.23 | $104K | +68.2% | — |
| Apr 3SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,209,840 held (−1%) | $5.99 | $100K | +75.0% | — |
| Apr 1SEC | James Aloysius BradyDirector | Sell Plan | 10,83489,166 held (−11%) | $5.54 | $60K | +89.2% | — |
| Mar 4SEC | Beth HechtSee Remarks | Sell Plan | 16,5671,226,607 held (−1%) | $6.24 | $103K | +67.9% | — |
| Mar 4SEC | Beth HechtSee Remarks | Sell Plan | 1001,226,507 held (−0%) | $7.06 | $706 | +48.4% | — |
| Feb 2SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,243,174 held (−1%) | $7.45 | $124K | +40.7% | — |
| Jan 9SEC | Kevin MccullochSee Remarks | Sell Plan | 15,0001,685,426 held (−1%) | $8.00 | $120K | +31.0% | — |
| Jan 6SEC | John Patrick Shannon Jr.See Remarks | Sell Plan | 24,9072,705,346 held (−1%) | $7.08 | $176K | +48.0% | — |
| Jan 5SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,308,103 held (−1%) | $7.43 | $124K | +41.0% | — |
| Dec 19SEC | John JohnsonDirector | Sell | 135,400698,083 held (−16%) | $7.22 | $978K | +45.2% | — |
| Dec 15SEC | Barbara-jean Anne Bormann-kennedyDirector | Sell Plan | 15,000142,500 held (−10%) | $7.09 | $106K | +47.8% | — |
| Dec 2SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,320,176 held (−1%) | $7.01 | $117K | +49.5% | — |
| Nov 17SEC | John Patrick Shannon Jr.See Remarks | Sell Plan | 23,2422,643,153 held (−1%) | $7.46 | $173K | +40.5% | — |
| Nov 13SEC | Beth HechtSee Remarks | Sell Plan | 16,6671,336,843 held (−1%) | $7.40 | $123K | +41.6% | — |
Insiders at Xeris Biopharma Holdings, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Kevin MccullochSee Remarks | — | $1.5M | Oct 2, 2026 | — |
| Beth HechtSee Remarks | — | $1.5M | Oct 2, 2026 | — |
| John JohnsonDirector | — | $1.1M | Jun 5, 2026 | — |
| Steven PieperSee Remarks | — | $515K | Oct 2, 2026 | — |
| John Patrick Shannon Jr.See Remarks | — | $350K | Jan 6, 2026 | — |
| Barbara-jean Anne Bormann-kennedyDirector | — | $204K | Jun 5, 2026 | — |
| Dawn HalkuffDirector | — | $122K | Jun 5, 2026 | — |
| Marla PerskyDirector | — | $91K | Jun 5, 2026 | — |
| James Aloysius BradyDirector | — | $60K | Apr 1, 2026 | — |
XERS stock: common questions
Are Xeris Biopharma Holdings, Inc. insiders buying XERS stock?
In the past 12 months, 0 insiders reported open-market purchases of XERS worth $0.
Are Xeris Biopharma Holdings, Inc. insiders selling XERS stock?
9 insiders reported sales worth $5.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is XERS's 52-week range?
Over the past year XERS has traded between $5.29 and $10.48. It last closed at $10.48 on Oct 9, 2026.